Följ
Morten Albrechtsen
Morten Albrechtsen
Okänd anknytning
Verifierad e-postadress på wexotec.com
Titel
Citeras av
Citeras av
År
A comparison of patient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery
DE Rosenow, M Albrechtsen, D Stolke
Anesthesia & Analgesia 86 (5), 1045-1050, 1998
2721998
Method and system for classifying a biological sample
L Noergaard, M Albrechtsen, OI Olsen, N Harrit, R Bro-Joergensen
US Patent 6,834,237, 2004
812004
Metod of modulation of interaction between receptor and ligand
E Bock, V Berezin, M Albrechtsen
US Patent App. 10/539,440, 2006
692006
Fluorescence spectroscopy and chemometrics for classification of breast cancer samples—a feasibility study using extended canonical variates analysis
L Nørgaard, G Sölétormos, N Harrit, M Albrechtsen, O Olsen, D Nielsen, ...
Journal of Chemometrics: A Journal of the Chemometrics Society 21 (10‐11 …, 2007
442007
The neural cell adhesion molecule-derived (NCAM)-peptide FG loop (FGL) mobilizes endogenous neural stem cells and promotes endogenous regenerative capacity after stroke
R Klein, N Mahlberg, M Ohren, A Ladwig, B Neumaier, R Graf, M Hoehn, ...
Journal of Neuroimmune Pharmacology 11, 708-720, 2016
222016
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo
R Klein, S Blaschke, B Neumaier, H Endepols, R Graf, M Keuters, ...
Stem cell reviews and reports 10, 539-547, 2014
192014
Compounds comprising lpa
M Albrechtsen, E Bock, V Berezin, AV Holm
US Patent App. 10/567,365, 2009
152009
Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease
M Albrechtsen, C Christensen, E Lukanidin, O Olsen
US Patent App. 10/520,741, 2007
142007
Effects of synthetic neural adhesion molecule mimetic peptides and related proteins on the cardiomyogenic differentiation of mouse embryonic stem cells
R Xu, SP Srinivasan, P Sureshkumar, EN Nembo, C Schäfer, J Semmler, ...
Cellular Physiology and Biochemistry 35 (6), 2437-2450, 2015
122015
Screening of bioactive peptides using an embryonic stem cell-based neurodifferentiation assay
R Xu, M Feyeux, S Julien, C Nemes, M Albrechtsen, A Dinnyés, ...
The AAPS journal 16, 400-412, 2014
122014
Method of modulation of interaction between receptor and ligand
V Berezin, E Bock, M Albrechtsen
US Patent App. 12/370,003, 2009
122009
Nanoparticle-guided radiotherapy
TL Andresen, M Albrechtsen
US Patent App. 13/810,588, 2013
112013
Formulation of solid nano-sized particles in a gel-forming system
RI Jolck, M Albrechtsen, LN Bjerg, TL Andresen
US Patent 10,064,960, 2018
92018
A comparison of patientcontrolled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery
DE RosenowM, M Albrechtsen, D Stolke
Anesth Analg 86 (9), 1045, 1998
81998
Chondrocyte cultures and fractions therefrom
O Olsen, M Albrechtsen, ML Little
US Patent App. 09/845,831, 2002
52002
Gel formulations for guiding radiotherapy
TL Andresen, RI Jolck, M Albrechtsen
US Patent 10,561,746, 2020
42020
Gel formulations for guiding radiotherapy
TL Andresen, RI Jølck, M Albrechtsen
EP Patent 3,003,397, 2016
12016
Nanoparticle-guided radiotherapy
M Albrechtsen, TL Andresen
AU Patent App. 2,011,278,308 A, 2014
12014
A upar (urokinase plasminogen activator receptor)-targeting conjugate
L Hartvig, GN Rasmussen, M Albrechtsen
US Patent App. 18/272,210, 2024
2024
Composition comprising a fluorophore labelled upar-targeting peptide conjugate
GN Rasmussen, A Kjaer, M Albrechtsen, L Hartvig
US Patent App. 17/792,336, 2023
2023
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20